Research Reveals Pancreatic Cancer Differences in Black African American Patients

Researchers at the University of Cincinnati Cancer Center have identified distinct molecular signatures in pancreatic cancer cells and immune environments between Black African American (BAA) and Non-African American (NAA) patients. Published in Cancer Research, these findings suggest that markers upregulated in BAA patients may be linked to drug resistance, potentially influencing treatment outcomes. This discovery could pave the way for more personalized and effective therapies.